TrialTrials2022

Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study).

Tomohisa Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.